US Stock MarketDetailed Quotes

CSBR Champions Oncology

Watchlist

4.520
+0.210+4.87%

Close Nov 29 13:00 ET

61.44MMarket Cap-17384P/E (TTM)

Champions Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Jul 31, 2024

(FY)Apr 30, 2024

(Q4)Apr 30, 2024

(Q3)Jan 31, 2024

(Q2)Oct 31, 2023

(Q1)Jul 31, 2023

(FY)Apr 30, 2023

(Q4)Apr 30, 2023

(Q3)Jan 31, 2023

(Q2)Oct 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

107.79%311K

-254.51%-6.14M

-162.43%-1.82M

-158.42%-919K

-82.08%589K

-1,946.67%-3.99M

-38.86%3.97M

-186.93%-692K

-63.05%1.57M

167.59%3.29M

Net income from continuing operations

151.17%1.31M

-36.38%-7.28M

95.74%-109K

-3.73%-2.53M

-12,843.75%-2.07M

-704.39%-2.57M

-1,073.54%-5.34M

-644.48%-2.56M

-409.91%-2.44M

-105.78%-16K

Operating gains losses

----

--435K

--354K

--16K

----

Depreciation and amortization

0.90%449K

-16.87%1.87M

-21.61%457K

-16.35%481K

-13.57%484K

-15.72%445K

38.05%2.25M

2.64%583K

45.20%575K

61.85%560K

Other non cash items

7.04%289K

11.97%1.07M

110.37%284K

1.82%280K

-15.02%232K

0.37%270K

21.12%952K

-46.22%135K

1,618.75%275K

-0.36%273K

Change In working capital

29.28%-1.93M

-190.10%-3.82M

-13,545.83%-3.23M

-86.97%375K

-20.99%1.75M

-210.01%-2.73M

81.64%4.24M

157.14%24K

4.73%2.88M

1,305.06%2.22M

-Change in receivables

151.41%565K

-252.22%-1.99M

-2,500.00%-1.79M

-126.51%-250K

317.39%1.15M

-795.57%-1.1M

146.42%1.31M

93.87%-69K

353.49%943K

155.65%276K

-Change in prepaid assets

8.07%241K

9.24%-167K

0.90%-660K

-131.98%-55K

162.10%325K

19.89%223K

1.60%-184K

-14.04%-666K

0.58%172K

-6.77%124K

-Change in payables and accrued expense

-355.28%-628K

-84.66%356K

-39.20%774K

1,083.02%627K

-172.49%-1.29M

131.26%246K

100.52%2.32M

410.49%1.27M

-86.09%53K

2,682.81%1.78M

-Change in other current assets

--0

---169K

--1K

---1K

--0

---169K

--0

-Change in other current liabilities

-10.62%-323K

-28.89%-1.17M

-136.36%-312K

-16.67%-308K

1.53%-257K

-16.80%-292K

-43.74%-907K

54.95%-132K

-26,300.00%-264K

1.14%-261K

-Change in other working capital

-9.06%-1.78M

-140.04%-683K

-223.56%-1.24M

-81.66%362K

508.33%1.83M

-778.49%-1.63M

-64.57%1.71M

-116.12%-382K

-23.16%1.97M

-53.92%300K

Cash from discontinued investing activities

Operating cash flow

107.79%311K

-254.51%-6.14M

-162.43%-1.82M

-158.42%-919K

-82.08%589K

-1,946.67%-3.99M

-38.86%3.97M

-186.93%-692K

-63.05%1.57M

167.59%3.29M

Investing cash flow

Cash flow from continuing investing activities

70.89%-836K

114.61%111K

83.29%-126K

74.67%-153K

11.41%-668K

-20.47%-2.87M

-50.20%-760K

-86.17%-754K

-6.71%-604K

Net PPE purchase and sale

--0

70.89%-836K

114.61%111K

83.29%-126K

74.67%-153K

11.41%-668K

-20.47%-2.87M

-50.20%-760K

-86.17%-754K

-6.71%-604K

Cash from discontinued investing activities

Investing cash flow

--0

70.89%-836K

114.61%111K

83.29%-126K

74.67%-153K

11.41%-668K

-20.47%-2.87M

-50.20%-760K

-86.17%-754K

-6.71%-604K

Financing cash flow

Cash flow from continuing financing activities

93.73%-37K

-4,890.91%-527K

-93.33%-145K

141.86%208K

-590K

-94.69%11K

-568.75%-75K

-28.93%86K

Net issuance payments of debt

---37K

---146K

----

--0

----

Net common stock issuance

--0

-756.76%-634K

--0

---32K

---602K

---74K

--0

Proceeds from stock option exercised by employees

--0

197.65%253K

200.00%1K

--0

179.07%240K

--12K

-58.94%85K

-106.25%-1K

--0

-28.93%86K

Cash from discontinued financing activities

Financing cash flow

93.73%-37K

-4,890.91%-527K

-93.33%-145K

--0

141.86%208K

---590K

-94.69%11K

-568.75%-75K

--0

-28.93%86K

Net cash flow

Beginning cash position

-74.13%2.62M

12.33%10.12M

-61.63%4.47M

-49.08%5.51M

-39.58%4.87M

12.33%10.12M

92.17%9.01M

33.84%11.65M

126.44%10.83M

101.55%8.06M

Current changes in cash

105.22%274K

-775.07%-7.5M

-21.15%-1.85M

-227.59%-1.05M

-76.73%644K

-453.11%-5.25M

-74.28%1.11M

-599.02%-1.53M

-79.11%819K

253.51%2.77M

End cash Position

-40.60%2.89M

-74.13%2.62M

-61.63%4.47M

-49.08%5.51M

-39.58%4.87M

12.33%10.12M

33.84%11.65M

126.44%10.83M

Free cash flow

106.68%311K

-733.91%-6.97M

-17.42%-1.71M

-227.59%-1.05M

-83.74%436K

-390.94%-4.66M

-73.26%1.1M

-600.69%-1.45M

-78.74%819K

305.14%2.68M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q1)Jul 31, 2024	(FY)Apr 30, 2024	(Q4)Apr 30, 2024	(Q3)Jan 31, 2024	(Q2)Oct 31, 2023	(Q1)Jul 31, 2023	(FY)Apr 30, 2023	(Q4)Apr 30, 2023	(Q3)Jan 31, 2023	(Q2)Oct 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	107.79%311K	-254.51%-6.14M	-162.43%-1.82M	-158.42%-919K	-82.08%589K	-1,946.67%-3.99M	-38.86%3.97M	-186.93%-692K	-63.05%1.57M	167.59%3.29M
Net income from continuing operations	151.17%1.31M	-36.38%-7.28M	95.74%-109K	-3.73%-2.53M	-12,843.75%-2.07M	-704.39%-2.57M	-1,073.54%-5.34M	-644.48%-2.56M	-409.91%-2.44M	-105.78%-16K
Operating gains losses	----	--435K	--354K	--16K	----	----	----	----	----	----
Depreciation and amortization	0.90%449K	-16.87%1.87M	-21.61%457K	-16.35%481K	-13.57%484K	-15.72%445K	38.05%2.25M	2.64%583K	45.20%575K	61.85%560K
Other non cash items	7.04%289K	11.97%1.07M	110.37%284K	1.82%280K	-15.02%232K	0.37%270K	21.12%952K	-46.22%135K	1,618.75%275K	-0.36%273K
Change In working capital	29.28%-1.93M	-190.10%-3.82M	-13,545.83%-3.23M	-86.97%375K	-20.99%1.75M	-210.01%-2.73M	81.64%4.24M	157.14%24K	4.73%2.88M	1,305.06%2.22M
-Change in receivables	151.41%565K	-252.22%-1.99M	-2,500.00%-1.79M	-126.51%-250K	317.39%1.15M	-795.57%-1.1M	146.42%1.31M	93.87%-69K	353.49%943K	155.65%276K
-Change in prepaid assets	8.07%241K	9.24%-167K	0.90%-660K	-131.98%-55K	162.10%325K	19.89%223K	1.60%-184K	-14.04%-666K	0.58%172K	-6.77%124K
-Change in payables and accrued expense	-355.28%-628K	-84.66%356K	-39.20%774K	1,083.02%627K	-172.49%-1.29M	131.26%246K	100.52%2.32M	410.49%1.27M	-86.09%53K	2,682.81%1.78M
-Change in other current assets	--0	---169K	--1K	---1K	--0	---169K	--0	--0	--0	--0
-Change in other current liabilities	-10.62%-323K	-28.89%-1.17M	-136.36%-312K	-16.67%-308K	1.53%-257K	-16.80%-292K	-43.74%-907K	54.95%-132K	-26,300.00%-264K	1.14%-261K
-Change in other working capital	-9.06%-1.78M	-140.04%-683K	-223.56%-1.24M	-81.66%362K	508.33%1.83M	-778.49%-1.63M	-64.57%1.71M	-116.12%-382K	-23.16%1.97M	-53.92%300K
Cash from discontinued investing activities
Operating cash flow	107.79%311K	-254.51%-6.14M	-162.43%-1.82M	-158.42%-919K	-82.08%589K	-1,946.67%-3.99M	-38.86%3.97M	-186.93%-692K	-63.05%1.57M	167.59%3.29M
Investing cash flow
Cash flow from continuing investing activities	0	70.89%-836K	114.61%111K	83.29%-126K	74.67%-153K	11.41%-668K	-20.47%-2.87M	-50.20%-760K	-86.17%-754K	-6.71%-604K
Net PPE purchase and sale	--0	70.89%-836K	114.61%111K	83.29%-126K	74.67%-153K	11.41%-668K	-20.47%-2.87M	-50.20%-760K	-86.17%-754K	-6.71%-604K
Cash from discontinued investing activities
Investing cash flow	--0	70.89%-836K	114.61%111K	83.29%-126K	74.67%-153K	11.41%-668K	-20.47%-2.87M	-50.20%-760K	-86.17%-754K	-6.71%-604K
Financing cash flow
Cash flow from continuing financing activities	93.73%-37K	-4,890.91%-527K	-93.33%-145K	0	141.86%208K	-590K	-94.69%11K	-568.75%-75K	0	-28.93%86K
Net issuance payments of debt	---37K	---146K	----	----	----	--0	--0	----	----	----
Net common stock issuance	--0	-756.76%-634K	--0	--0	---32K	---602K	---74K	---74K	--0	--0
Proceeds from stock option exercised by employees	--0	197.65%253K	200.00%1K	--0	179.07%240K	--12K	-58.94%85K	-106.25%-1K	--0	-28.93%86K
Cash from discontinued financing activities
Financing cash flow	93.73%-37K	-4,890.91%-527K	-93.33%-145K	--0	141.86%208K	---590K	-94.69%11K	-568.75%-75K	--0	-28.93%86K
Net cash flow
Beginning cash position	-74.13%2.62M	12.33%10.12M	-61.63%4.47M	-49.08%5.51M	-39.58%4.87M	12.33%10.12M	92.17%9.01M	33.84%11.65M	126.44%10.83M	101.55%8.06M
Current changes in cash	105.22%274K	-775.07%-7.5M	-21.15%-1.85M	-227.59%-1.05M	-76.73%644K	-453.11%-5.25M	-74.28%1.11M	-599.02%-1.53M	-79.11%819K	253.51%2.77M
End cash Position	-40.60%2.89M	-74.13%2.62M	-74.13%2.62M	-61.63%4.47M	-49.08%5.51M	-39.58%4.87M	12.33%10.12M	12.33%10.12M	33.84%11.65M	126.44%10.83M
Free cash flow	106.68%311K	-733.91%-6.97M	-17.42%-1.71M	-227.59%-1.05M	-83.74%436K	-390.94%-4.66M	-73.26%1.1M	-600.69%-1.45M	-78.74%819K	305.14%2.68M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data